Cargando…
Serum thymidine kinase 1 concentration as a predictive biomarker in prostate cancer
BACKGROUND: Thymidine kinase 1 (TK1) recycles DNA before cell division. We do not know if baseline blood concentrations of TK1 predict death in prostate cancer within 30 years. Our objective is to determine if there is an association between baseline levels of TK1 and future prostate cancer‐specific...
Autores principales: | Lundgren, Per‐Olof, Tribukait, Bernhard, Kjellman, Anders, Norming, Ulf, Jagarlmudi, Kiran, Gustafsson, Ove |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9311431/ https://www.ncbi.nlm.nih.gov/pubmed/35294068 http://dx.doi.org/10.1002/pros.24335 |
Ejemplares similares
-
Prediction of Overall Survival by Thymidine Kinase 1 Combined with Prostate-Specific Antigen in Men with Prostate Cancer
por: Tribukait, Bernhard, et al.
Publicado: (2023) -
Dynamics of Serum Thymidine Kinase 1 at the First Cycle of Neoadjuvant Chemotherapy Predicts Outcome of Disease in Estrogen-Receptor-Positive Breast Cancer
por: Tribukait, Bernhard
Publicado: (2021) -
Early prediction of pathologic response to neoadjuvant treatment of breast cancer: use of a cell-loss metric based on serum thymidine kinase 1 and tumour volume
por: Tribukait, Bernhard
Publicado: (2020) -
Investigation on Cell Proliferation with a New Antibody against Thymidine Kinase 1
por: Wang, Naining, et al.
Publicado: (2001) -
Breast and prostate cancer patients differ significantly in their serum Thymidine kinase 1 (TK1) specific activities compared with those hematological malignancies and blood donors: implications of using serum TK1 as a biomarker
por: Jagarlamudi, Kiran Kumar, et al.
Publicado: (2015)